PTGX icon

Protagonist Therapeutics

136 hedge funds and large institutions have $1.22B invested in Protagonist Therapeutics in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

3% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 32

0% more funds holding

Funds holding: 136136 (0)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$42.3M
Puts
$13.2M
Net Calls
Net Calls Change

Top Buyers

1 +$86.8M
2 +$41.2M
3 +$39.1M
4
RI
RTW Investments
New York
+$23.2M
5
PA
Perceptive Advisors
New York
+$22.2M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$402K
102
$397K
103
$357K
104
$351K
105
$345K
106
$324K
107
$315K
108
$311K
109
$281K
110
$276K
111
$276K
112
$273K
113
$267K
114
$261K
115
$260K
116
$246K
117
$237K
118
$234K
119
$213K
120
$204K
121
$200K
122
$109K
123
$80.5K
124
$61K
125
$58K